DAP Health has received the new twice-yearly injection for HIV prevention. Here's what you need to know if you're interested ...

The FDA has approved a twice-yearly injection for HIV prevention following a groundbreaking clinical trial. Years before the ...

The $400 million that the United States Congress removed from a list of programmes from which the Trump administration wants ...

Yeztugo, a twice yearly injection, offers a promising advancement in HIV prevention, but high costs and insurance uncertainties may limit its accessibility.

Congress removed from a list of programmes from which the Trump administration wants to cut funds, doesn't cancel the cuts to global HIV and TB programmes made in February . HIV projects that have ...

The Midwest AIDS Training and Education Center’s funding will be cut completely in the current budget proposal for fiscal ...

Last week, the President’s Emergency Plan for AIDS Relief narrowly avoided a $400 million budget cut, thanks to bipartisan support. However, preserving PEPFAR should not be the ultimate goal; global ...

HIV prevention is entering a new phase with the rise of innovative medications like the twice-yearly injectable lenacapavir.

Lenacapavir, a new HIV prevention injection, will offer six months of protection per dose at a cost of Sh6,000, according to ...